| Chelsea M Williams, MD | |
|
213 E Kimball St, Callaway, NE 68825-2596 | |
| (308) 836-2294 | |
| (402) 836-2733 |
| Full Name | Chelsea M Williams |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 10 Years |
| Location | 213 E Kimball St, Callaway, Nebraska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083025803 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 29300 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aseracare Hospice | Kearney, NE | Hospice |
| Callaway District Hospital | Callaway, NE | Hospital |
| Kearney Regional Medical Center | Kearney, NE | Hospital |
| Jennie M Melham Memorial Medical Center | Broken bow, NE | Hospital |
| Callaway Good Life Center, Inc | Callaway, NE | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Callaway Hospital District | 0143208983 | 5 |
News Archive
Impax Laboratories, Inc. today announced that it will collaborate with Perrigo Company with respect to the development and commercialization of two extended topical drug products. The products and terms of the agreement were not disclosed.
Silence Therapeutics plc announces the issuance of two new patents by the United States Patent and Trademark Office (USPTO) which are broadly directed to double-stranded short interfering RNA (siRNA) sequences against the validated cancer targets epidermal growth factor receptor related protein (EGFR-RP) and vascular endothelial growth factor receptor 1 (VEGFR1).
Driving a car at 40 mph, you see a child dart into the street. You hit the brakes. Disaster averted. But how did your eyes detect that movement? It's a question that has confounded scientists. Now, studying mice, researchers at Washington University School of Medicine in St. Louis have an answer: A neural circuit in the retina at the back of the eye carries signals that enable the eye to detect movement.
The study included four radiologists who interpreted 268 digital screening mammograms and 189 film-screening mammograms. "The average interpretation time for all of our readers was 240 seconds (4 minutes) for digital screening mammograms and 127 seconds (2 minutes, 7 seconds) for film-screen screening mammograms," said Tamara Miner Haygood, MD, lead author of the study.
› Verified 3 days ago
| Entity Name | Callaway Hospital District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508979899 PECOS PAC ID: 0143208983 Enrollment ID: O20040714000240 |
News Archive
Impax Laboratories, Inc. today announced that it will collaborate with Perrigo Company with respect to the development and commercialization of two extended topical drug products. The products and terms of the agreement were not disclosed.
Silence Therapeutics plc announces the issuance of two new patents by the United States Patent and Trademark Office (USPTO) which are broadly directed to double-stranded short interfering RNA (siRNA) sequences against the validated cancer targets epidermal growth factor receptor related protein (EGFR-RP) and vascular endothelial growth factor receptor 1 (VEGFR1).
Driving a car at 40 mph, you see a child dart into the street. You hit the brakes. Disaster averted. But how did your eyes detect that movement? It's a question that has confounded scientists. Now, studying mice, researchers at Washington University School of Medicine in St. Louis have an answer: A neural circuit in the retina at the back of the eye carries signals that enable the eye to detect movement.
The study included four radiologists who interpreted 268 digital screening mammograms and 189 film-screening mammograms. "The average interpretation time for all of our readers was 240 seconds (4 minutes) for digital screening mammograms and 127 seconds (2 minutes, 7 seconds) for film-screen screening mammograms," said Tamara Miner Haygood, MD, lead author of the study.
› Verified 3 days ago
| Entity Name | Callaway Hospital District |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1740397850 PECOS PAC ID: 0143208983 Enrollment ID: O20071128000819 |
News Archive
Impax Laboratories, Inc. today announced that it will collaborate with Perrigo Company with respect to the development and commercialization of two extended topical drug products. The products and terms of the agreement were not disclosed.
Silence Therapeutics plc announces the issuance of two new patents by the United States Patent and Trademark Office (USPTO) which are broadly directed to double-stranded short interfering RNA (siRNA) sequences against the validated cancer targets epidermal growth factor receptor related protein (EGFR-RP) and vascular endothelial growth factor receptor 1 (VEGFR1).
Driving a car at 40 mph, you see a child dart into the street. You hit the brakes. Disaster averted. But how did your eyes detect that movement? It's a question that has confounded scientists. Now, studying mice, researchers at Washington University School of Medicine in St. Louis have an answer: A neural circuit in the retina at the back of the eye carries signals that enable the eye to detect movement.
The study included four radiologists who interpreted 268 digital screening mammograms and 189 film-screening mammograms. "The average interpretation time for all of our readers was 240 seconds (4 minutes) for digital screening mammograms and 127 seconds (2 minutes, 7 seconds) for film-screen screening mammograms," said Tamara Miner Haygood, MD, lead author of the study.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Chelsea M Williams, MD Po Box 100, Callaway, NE 68825-0100 Ph: (308) 836-2294 | Chelsea M Williams, MD 213 E Kimball St, Callaway, NE 68825-2596 Ph: (308) 836-2294 |
News Archive
Impax Laboratories, Inc. today announced that it will collaborate with Perrigo Company with respect to the development and commercialization of two extended topical drug products. The products and terms of the agreement were not disclosed.
Silence Therapeutics plc announces the issuance of two new patents by the United States Patent and Trademark Office (USPTO) which are broadly directed to double-stranded short interfering RNA (siRNA) sequences against the validated cancer targets epidermal growth factor receptor related protein (EGFR-RP) and vascular endothelial growth factor receptor 1 (VEGFR1).
Driving a car at 40 mph, you see a child dart into the street. You hit the brakes. Disaster averted. But how did your eyes detect that movement? It's a question that has confounded scientists. Now, studying mice, researchers at Washington University School of Medicine in St. Louis have an answer: A neural circuit in the retina at the back of the eye carries signals that enable the eye to detect movement.
The study included four radiologists who interpreted 268 digital screening mammograms and 189 film-screening mammograms. "The average interpretation time for all of our readers was 240 seconds (4 minutes) for digital screening mammograms and 127 seconds (2 minutes, 7 seconds) for film-screen screening mammograms," said Tamara Miner Haygood, MD, lead author of the study.
› Verified 3 days ago
Ronald John Sheppard, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 213 E Kimball St, Callaway, NE 68825 Phone: 308-836-2294 Fax: 308-836-2733 | |
Tiffany L Svoboda, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 213 E Kimball St, Callaway, NE 68825 Phone: 308-836-2294 Fax: 402-836-2733 | |
Kenneth Leroy Loper, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 213 E Kimball St, Callaway, NE 68825 Phone: 308-836-2294 Fax: 308-836-2451 |